Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation

Ricardo Saban, Michael R. D'Andrea, Patricia Andrade-Gordon, Claudia K. Derian, Igor Dozmorov, Michael A. Ihnat, Robert E. Hurst, Carole A. Davis, Cindy Simpson, Marcia R. Saban

Research output: Contribution to journalArticle

16 Citations (Scopus)

Abstract

Background. In general, inflammation plays a role in most bladder pathologies and represents a defense reaction to injury that often times is two edged. In particular, bladder neurogenic inflammation involves the participation of mast cells and sensory nerves. Increased mast cell numbers and tryptase release represent one of the prevalent etiologic theories for interstitial cystitis and other urinary bladder inflammatory conditions. The activity of mast cell-derived tryptase as well as thrombin is significantly increased during inflammation. Those enzymes activate specific G-protein coupled proteinase-activated receptors (PAR)s. Four PARs have been cloned so far, and not only are all four receptors highly expressed in different cell types of the mouse urinary bladder, but their expression is altered during experimental bladder inflammation. We hypothesize that PARs may link mast cell-derived proteases to bladder inflammation and, therefore, play a fundamental role in the pathogenesis of cystitis. Results. Here, we demonstrate that in addition to the mouse urinary bladder, all four PA receptors are also expressed in the J82 human urothelial cell line. Intravesical administration of PAR-activating peptides in mice leads to an inflammatory reaction characterized by edema and granulocyte infiltration. Moreover, the inflammatory response to intravesical instillation of known pro-inflammatory stimuli such as E. coli lipopolysaccharide (LPS), substance P, and antigen was strongly attenuated by PAR1-, and to a lesser extent, by PAR2-deficiency. Conclusion. Our results reveal an overriding participation of PAR1 in bladder inflammation, provide a working model for the involvement of downstream signaling, and evoke testable hypotheses regarding the role of PARs in bladder inflammation. It remains to be determined whether or not mechanisms targeting PAR1 gene silencing or PAR1 blockade will ameliorate the clinical manifestations of cystitis.

Original languageEnglish (US)
Article number4
JournalBMC Physiology
Volume7
DOIs
StatePublished - 2007

Fingerprint

PAR-1 Receptor
Urinary Bladder
Inflammation
Proteinase-Activated Receptors
Intravesical Administration
Tryptases
Cystitis
Mast Cells
Neurogenic Inflammation
Interstitial Cystitis
Gene Silencing
Substance P
GTP-Binding Proteins
Granulocytes
Thrombin
Lipopolysaccharides
Edema
Peptide Hydrolases
Cell Count
Pathology

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Saban, R., D'Andrea, M. R., Andrade-Gordon, P., Derian, C. K., Dozmorov, I., Ihnat, M. A., ... Saban, M. R. (2007). Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation. BMC Physiology, 7, [4]. https://doi.org/10.1186/1472-6793-7-4

Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation. / Saban, Ricardo; D'Andrea, Michael R.; Andrade-Gordon, Patricia; Derian, Claudia K.; Dozmorov, Igor; Ihnat, Michael A.; Hurst, Robert E.; Davis, Carole A.; Simpson, Cindy; Saban, Marcia R.

In: BMC Physiology, Vol. 7, 4, 2007.

Research output: Contribution to journalArticle

Saban, R, D'Andrea, MR, Andrade-Gordon, P, Derian, CK, Dozmorov, I, Ihnat, MA, Hurst, RE, Davis, CA, Simpson, C & Saban, MR 2007, 'Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation', BMC Physiology, vol. 7, 4. https://doi.org/10.1186/1472-6793-7-4
Saban, Ricardo ; D'Andrea, Michael R. ; Andrade-Gordon, Patricia ; Derian, Claudia K. ; Dozmorov, Igor ; Ihnat, Michael A. ; Hurst, Robert E. ; Davis, Carole A. ; Simpson, Cindy ; Saban, Marcia R. / Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation. In: BMC Physiology. 2007 ; Vol. 7.
@article{fd4b5d1e2586443dab033cdcde8eb9a3,
title = "Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation",
abstract = "Background. In general, inflammation plays a role in most bladder pathologies and represents a defense reaction to injury that often times is two edged. In particular, bladder neurogenic inflammation involves the participation of mast cells and sensory nerves. Increased mast cell numbers and tryptase release represent one of the prevalent etiologic theories for interstitial cystitis and other urinary bladder inflammatory conditions. The activity of mast cell-derived tryptase as well as thrombin is significantly increased during inflammation. Those enzymes activate specific G-protein coupled proteinase-activated receptors (PAR)s. Four PARs have been cloned so far, and not only are all four receptors highly expressed in different cell types of the mouse urinary bladder, but their expression is altered during experimental bladder inflammation. We hypothesize that PARs may link mast cell-derived proteases to bladder inflammation and, therefore, play a fundamental role in the pathogenesis of cystitis. Results. Here, we demonstrate that in addition to the mouse urinary bladder, all four PA receptors are also expressed in the J82 human urothelial cell line. Intravesical administration of PAR-activating peptides in mice leads to an inflammatory reaction characterized by edema and granulocyte infiltration. Moreover, the inflammatory response to intravesical instillation of known pro-inflammatory stimuli such as E. coli lipopolysaccharide (LPS), substance P, and antigen was strongly attenuated by PAR1-, and to a lesser extent, by PAR2-deficiency. Conclusion. Our results reveal an overriding participation of PAR1 in bladder inflammation, provide a working model for the involvement of downstream signaling, and evoke testable hypotheses regarding the role of PARs in bladder inflammation. It remains to be determined whether or not mechanisms targeting PAR1 gene silencing or PAR1 blockade will ameliorate the clinical manifestations of cystitis.",
author = "Ricardo Saban and D'Andrea, {Michael R.} and Patricia Andrade-Gordon and Derian, {Claudia K.} and Igor Dozmorov and Ihnat, {Michael A.} and Hurst, {Robert E.} and Davis, {Carole A.} and Cindy Simpson and Saban, {Marcia R.}",
year = "2007",
doi = "10.1186/1472-6793-7-4",
language = "English (US)",
volume = "7",
journal = "BMC Physiology",
issn = "1472-6793",
publisher = "BioMed Central",

}

TY - JOUR

T1 - Mandatory role of proteinase-activated receptor 1 in experimental bladder inflammation

AU - Saban, Ricardo

AU - D'Andrea, Michael R.

AU - Andrade-Gordon, Patricia

AU - Derian, Claudia K.

AU - Dozmorov, Igor

AU - Ihnat, Michael A.

AU - Hurst, Robert E.

AU - Davis, Carole A.

AU - Simpson, Cindy

AU - Saban, Marcia R.

PY - 2007

Y1 - 2007

N2 - Background. In general, inflammation plays a role in most bladder pathologies and represents a defense reaction to injury that often times is two edged. In particular, bladder neurogenic inflammation involves the participation of mast cells and sensory nerves. Increased mast cell numbers and tryptase release represent one of the prevalent etiologic theories for interstitial cystitis and other urinary bladder inflammatory conditions. The activity of mast cell-derived tryptase as well as thrombin is significantly increased during inflammation. Those enzymes activate specific G-protein coupled proteinase-activated receptors (PAR)s. Four PARs have been cloned so far, and not only are all four receptors highly expressed in different cell types of the mouse urinary bladder, but their expression is altered during experimental bladder inflammation. We hypothesize that PARs may link mast cell-derived proteases to bladder inflammation and, therefore, play a fundamental role in the pathogenesis of cystitis. Results. Here, we demonstrate that in addition to the mouse urinary bladder, all four PA receptors are also expressed in the J82 human urothelial cell line. Intravesical administration of PAR-activating peptides in mice leads to an inflammatory reaction characterized by edema and granulocyte infiltration. Moreover, the inflammatory response to intravesical instillation of known pro-inflammatory stimuli such as E. coli lipopolysaccharide (LPS), substance P, and antigen was strongly attenuated by PAR1-, and to a lesser extent, by PAR2-deficiency. Conclusion. Our results reveal an overriding participation of PAR1 in bladder inflammation, provide a working model for the involvement of downstream signaling, and evoke testable hypotheses regarding the role of PARs in bladder inflammation. It remains to be determined whether or not mechanisms targeting PAR1 gene silencing or PAR1 blockade will ameliorate the clinical manifestations of cystitis.

AB - Background. In general, inflammation plays a role in most bladder pathologies and represents a defense reaction to injury that often times is two edged. In particular, bladder neurogenic inflammation involves the participation of mast cells and sensory nerves. Increased mast cell numbers and tryptase release represent one of the prevalent etiologic theories for interstitial cystitis and other urinary bladder inflammatory conditions. The activity of mast cell-derived tryptase as well as thrombin is significantly increased during inflammation. Those enzymes activate specific G-protein coupled proteinase-activated receptors (PAR)s. Four PARs have been cloned so far, and not only are all four receptors highly expressed in different cell types of the mouse urinary bladder, but their expression is altered during experimental bladder inflammation. We hypothesize that PARs may link mast cell-derived proteases to bladder inflammation and, therefore, play a fundamental role in the pathogenesis of cystitis. Results. Here, we demonstrate that in addition to the mouse urinary bladder, all four PA receptors are also expressed in the J82 human urothelial cell line. Intravesical administration of PAR-activating peptides in mice leads to an inflammatory reaction characterized by edema and granulocyte infiltration. Moreover, the inflammatory response to intravesical instillation of known pro-inflammatory stimuli such as E. coli lipopolysaccharide (LPS), substance P, and antigen was strongly attenuated by PAR1-, and to a lesser extent, by PAR2-deficiency. Conclusion. Our results reveal an overriding participation of PAR1 in bladder inflammation, provide a working model for the involvement of downstream signaling, and evoke testable hypotheses regarding the role of PARs in bladder inflammation. It remains to be determined whether or not mechanisms targeting PAR1 gene silencing or PAR1 blockade will ameliorate the clinical manifestations of cystitis.

UR - http://www.scopus.com/inward/record.url?scp=34247348089&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=34247348089&partnerID=8YFLogxK

U2 - 10.1186/1472-6793-7-4

DO - 10.1186/1472-6793-7-4

M3 - Article

VL - 7

JO - BMC Physiology

JF - BMC Physiology

SN - 1472-6793

M1 - 4

ER -